£70.99

About as cheap as it gets — within 5% of the all-time low it hit 3 months ago.

£71 today · all-time low £68 (Jul 2026) · usually the usual

CRC Press RNA Delivery Function for Anticancer Therapeutics (Nanotechnology for Drugs, Vaccines and Smart Delivery Systems)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 57 days · 57 data points (no recent data)

Historical
Generating forecast…
£71.05 £68.07 £68.72 £69.37 £70.02 £70.67 £71.32 22 July 2026 05 August 2026 19 August 2026 02 September 2026 16 September 2026
View at Amazon ↗

Price data last checked 34 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 57 days • 2 price levels

Days at Price
Current Price
21 days 36 days · current 0 9 18 27 36 £68 £71 Days at Price

Price Analysis

Most common price: £71 (36 days, 63.2%)

Price range: £68 - £71

Price levels: 2 different prices over 57 days

Description

This book presents an overview of the current status of translating the RNAi cancer therapeutics in the clinic, a brief description of the biological barriers in drug delivery, and the roles of imaging in aspects of administration route, systemic circulation, and cellular barriers for the clinical translation of RNAi cancer therapeutics, and with partial content for discussing the safety concerns. It then focuses on imaging-guided delivery of RNAi therapeutics in preclinical development, including the basic principles of different imaging modalities, and their advantages and limitations for biological imaging. With growing number of RNAi therapeutics entering the clinic, various imaging methods will play an important role in facilitating the translation of RNAi cancer therapeutics from bench to bedside. RNAi technique has become a powerful tool for basic research to selectively knock down gene expression in vitro and in vivo. Our scientific and industrial communities have started to develop RNAi therapeutics as the next class of drugs for treating a variety of genetic disorders, such as cancer and other diseases that are particularly hard to address with current treatment strategies. Key Features Provides insight into the current advances and hurdles of RNAi therapeutics. Accelerates RNAi, miRNAs, and siRNA drug development for cancer therapy from bench to bedside. Addresses various modifications and novel delivery strategies for miRNAs, piRNAs and siRNA delivery in anticancer therapeutics. Explores the need for the interaction of hematologists,cell biologists, immunologists, and material scientists in the development of novel cancer therapies. Describes the current status of clinical trials related to miRNA and siRNA-based cancer therapy Presents remaining issues that need to be overcome to establish successful therapies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
04 October 2024
Listed Since
10 August 2024

Barcode

No barcode data available

Similar Products You Might Like

Nanoparticle-Based Drug Delivery in Cancer Treatment (Nanotechnology for Drugs, Vaccines and Smart Delivery Systems)
92% match

Nanoparticle-Based Drug Delivery in Cancer Treatment (Nanotechnology for Drugs, Vaccines and Smart Delivery Systems)

CRC Press

£77.00 16 Sep 2026
Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)
87% match

Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)

Springer

£114.71 04 Aug 2026
Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)
86% match

Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)

Humana

£73.14 07 Aug 2026
DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases (RNA Technologies)
86% match

DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases (RNA Technologies)

Springer

£108.01 05 Aug 2026
RNA Therapeutics: Function, Design, and Delivery: 629 (Methods in Molecular Biology, 629)
85% match

RNA Therapeutics: Function, Design, and Delivery: 629 (Methods in Molecular Biology, 629)

Humana

£81.74 06 Aug 2026
Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices
85% match

Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices

Elsevier

£119.82 08 Aug 2026
Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies
85% match

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Elsevier

£141.99 06 Aug 2026
Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)
84% match

Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)

Wiley

£110.03 04 Aug 2026
Functional Smart Nanomaterials and Their Theranostics Approaches (Smart Nanomaterials Technology)
84% match

Functional Smart Nanomaterials and Their Theranostics Approaches (Smart Nanomaterials Technology)

Springer

£139.99 15 Sep 2026
Understanding Cancer Therapies
84% match

Understanding Cancer Therapies

CRC Press

£52.99 14 Sep 2026
Pharmaceutical Perspectives of Cancer Therapeutics
84% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 08 Aug 2026
Nanoarchitectonics for Brain Drug Delivery (Advances in Bionanotechnology)
83% match

Nanoarchitectonics for Brain Drug Delivery (Advances in Bionanotechnology)

CRC Press

£61.46 15 Sep 2026
In-Vitro and In-Vivo Tools in Drug Delivery Research for Optimum Clinical Outcomes
83% match

In-Vitro and In-Vivo Tools in Drug Delivery Research for Optimum Clinical Outcomes

CRC Press

£51.99 16 Sep 2026
Nanotechnology in Cancer (Micro and Nano Technologies)
83% match

Nanotechnology in Cancer (Micro and Nano Technologies)

Elsevier

£97.99 29 Aug 2026
Exploring Nanocarriers in Breast Cancer Management
83% match

Exploring Nanocarriers in Breast Cancer Management

Elsevier

£125.02 17 Oct 2026
MicroRNAs in Cancer Translational Research
83% match

MicroRNAs in Cancer Translational Research

Springer

£141.27 29 Aug 2026
MicroRNAs in Cancer Translational Research
83% match

MicroRNAs in Cancer Translational Research

Springer

£110.00 04 Aug 2026
Nanomedicine: A Soft Matter Perspective
82% match

Nanomedicine: A Soft Matter Perspective

CRC Press

£140.00 04 Aug 2026
Messenger RNA Therapeutics: 13 (RNA Technologies, 13)
82% match

Messenger RNA Therapeutics: 13 (RNA Technologies, 13)

Springer

£107.98 19 Aug 2026
Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)
82% match

Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£161.59 07 Aug 2026
Pharmaceutical Nanobiotechnology for Targeted Therapy (Nanotechnology in the Life Sciences)
82% match

Pharmaceutical Nanobiotechnology for Targeted Therapy (Nanotechnology in the Life Sciences)

Springer

£104.02 15 Sep 2026
siRNA and miRNA Gene Silencing: From Bench to Bedside: 487 (Methods in Molecular Biology, 487)
82% match

siRNA and miRNA Gene Silencing: From Bench to Bedside: 487 (Methods in Molecular Biology, 487)

Humana

£110.27 06 Aug 2026
Functional Nanomaterials in Biomedicine
82% match

Functional Nanomaterials in Biomedicine

£64.26 15 Sep 2026
Cancer Gene Therapy (Contemporary Cancer Research)
82% match

Cancer Gene Therapy (Contemporary Cancer Research)

Humana

£169.87 06 Aug 2026